drugset / Trial / NCT00987909

Exposure Chamber Trial With Cat Immunotherapy

NCT00987909 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The main purpose of this trial is to investigate if any of three different doses of cat hair immunotherapy is safe for treatment of cat allergic patients.

Timeline

Start
2009-09
Primary completion
2010-03
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Cat hair allergen extract Unknown 4.5 ug Other
Subject Cat hair allergen extract Unknown 9 ug Other
Subject Cat hair allergen extract Unknown 18 ug Other

Indications

No indication recorded.